Skip to content

Locomotor Experience Applied Post Stroke Trial

Locomotor Experience Applied Post Stroke (LEAPS) Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00243919
Acronym
LEAPS
Enrollment
408
Registered
2005-10-25
Start date
2006-04-30
Completion date
2012-06-30
Last updated
2014-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, locomotor, exercise, walking, training program, body weight support training, physical therapy

Brief summary

The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).

Detailed description

The impact of stroke on walking is significant, with only 37 percent of stroke survivors able to walk after the first week after stroke (or post-stroke). Even among those who achieve independent ambulation, significant residual deficits persist in balance and gait speed with a 73 percent incidence of falls among individuals with mild to moderate impairment 6 months post-stroke. Body weight supported treadmill training is one therapeutic method for locomotor training that is rapidly being adopted into physical rehabilitation to improve walking after stroke. The purpose of this multi-center, randomized controlled study is to compare two different treatments to improve walking after stroke. The two treatments are: 1) a training program that includes use of a body weight support system and a treadmill to practice walking and 2) a physical therapist monitored exercise program to work on general conditioning and strengthening in the patient's home. In addition, investigators will determine the best time to provide training after a stroke and if the training is beneficial for mild, moderate, or severe cases of stroke. Four hundred subjects will be recruited from five facilities in Florida and California. Screening and subject recruitment will take place within 45 days post-stroke. All stroke patients will be screened to determine eligibility for the study. Eligible subjects will be followed for 2 months post-stroke. At that time, those who are eligible for enrollment and who consent to participate will undergo an exercise tolerance test and baseline assessment. Following this evaluation, participants will be randomized into one of three groups, according to the severity of their locomotor impairment: early locomotor, late locomotor, or early home exercise. The early locomotor training group will begin the locomotor training program immediately (2 months post stroke). The locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill. The late locomotor training group will begin locomotor training at 6 months post-stroke. Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning immediately (2 months post stroke).

Interventions

BEHAVIORALEarly locomotor training program

The early locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 2 months post-stroke.

BEHAVIORALLate locomotor training program

The late locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 6 months post-stroke.

BEHAVIORALHome Exercise Program

Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning at 2 months post stroke.

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>/=18 * Stroke within 45-days * Residual paresis in the lower extremity (fugl-meyer le motor score \< 34) * Ability to sit unsupported for 30 seconds * Ability to walk at least 10 feet with maximum 1 person assist * Ability to follow a three step command * Provision of informed consent * A self-selected 10 meter gait speed less than 0.8 m/s at the 2-month post-stroke assessment * Successful completion of an exercise tolerance test

Exclusion criteria

* Lived in nursing home prior to stroke * Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking less than 200 meters * Serious cardiac conditions (history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living). Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded * History of serious chronic obstructive pulmonary disease or oxygen dependence * Severe weight bearing pain * Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia, or previous stroke with residual neurological deficits * History of major head trauma * Lower extremity amputation * Non-healing ulcers on the lower extremity * Renal dialysis or end stage liver disease * Legal blindness or severe visual impairment * A history of significant psychiatric illness defined by diagnosis of bipolar affective disorder, psychosis, schizophrenia or medication refractory depression * Life expectancy less than one year * Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion (ROM) \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15° * History of sustained alcoholism or drug abuse in the last six months * Major post-stroke depression as measured by the Patient Health Questionnaire(PHQ-9 \>/= 10) that is not medically managed with antidepressant medication and/or psychotherapy * History of pulmonary embolism within 6 months * Uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions * Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest, * Previous or current enrollment in a clinical trial to enhance stroke motor recovery * Lives more than 50 miles from the training sites * Unable to travel 3 times per week for outpatient training programs * Intracranial hemorrhage related to aneurysmal rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded) Inclusion and

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke12 months post-strokeSuccess: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
Walking Speed: Measured During a 10-meter WalkBaseline and 12 months post-stroke

Secondary

MeasureTime frameDescription
6 Minute Walking Distance (Meters)Baseline, 6 months and 12 months post-strokeDistance walked in 6 minutes.
Step Activity Monitor (SAM)- Median of Average Number of Steps Per DayBaseline, 6 months and 12 months post-strokeAs measured with a step activity monitor averaged over 2 days.
Stroke Impact Scale (SIS) - ParticipationBaseline, 6 months and 12 months post-strokeRange = 0 - 100. The Stroke Impact Scale is a measure of function (including ADL-IADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.
Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)Baseline, 6 months and 12 months post-strokeRange 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.
Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-strokeBaseline and 6 months post-strokeSuccess: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
Fugl-Meyer Lower Extremity ScoreBaseline, 6 months and 12 months post-strokeRange 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.
Berg Balance ScoreBaseline, 6 months and 12 months post-strokeRange = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.
Activities Specific Balance Confidence (ABC) ScoreBaseline, 6 months and 12 months post-strokeRange = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.
Stroke Impact Scale (SIS) - MobilityBaseline, 6 months and 12 months post-strokeRange = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.
6 Month Outcome: Walking Speed: Measured During a 10-meter WalkBaseline and 6 months post-stroke

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 6 inpatient rehabilitation centers in California and Florida from April 2006 through June 2009.

Pre-assignment details

Participants admitted for inpatient rehabilitation were screened by chart review. Eligible participants with first-time stroke received a comprehensive medical record review and physical and cognitive screening. At 2-months, those who maintained eligibility and successfully completed an exercise tolerance test were enrolled.

Participants by arm

ArmCount
Early Locomotor Training Program
Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.
139
Late Locomotor Training Program
Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.
143
Home Exercise Program
HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.
126
Total408

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyAdministrative Error100
Overall StudyDeath346
Overall StudyLost to Follow-up673
Overall StudyPhysician Decision110
Overall StudyWithdrawal by Subject662

Baseline characteristics

CharacteristicLate Locomotor Training ProgramTotalHome Exercise ProgramEarly Locomotor Training Program
Age, Continuous63.3 years
STANDARD_DEVIATION 12.5
62.0 years
STANDARD_DEVIATION 12.7
62.6 years
STANDARD_DEVIATION 13.3
60.1 years
STANDARD_DEVIATION 12.3
Comfortable walking speed (m/sec)0.38 m/sec
STANDARD_DEVIATION 0.23
0.38 m/sec
STANDARD_DEVIATION 0.22
0.39 m/sec
STANDARD_DEVIATION 0.22
0.36 m/sec
STANDARD_DEVIATION 0.22
Comorbidities
Arthritis/other musculoskeletal
52 participants146 participants47 participants47 participants
Comorbidities
Cardiovascular
36 participants109 participants37 participants36 participants
Comorbidities
Chronic Obstructive Pulmonary Disease (COPD)
14 participants26 participants7 participants5 participants
Comorbidities
Depression (Personal Health Questionnaire-9 >= 10)
28 participants67 participants19 participants20 participants
Comorbidities
Diabetes
51 participants141 participants43 participants47 participants
Comorbidities
Hypertension
111 participants331 participants104 participants116 participants
Comorbidities
Peripheral vascular disease
12 participants37 participants13 participants12 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants63 Participants22 Participants26 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
128 Participants345 Participants104 Participants113 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Mini Mental Status Exam26.2 scores on a scale
STANDARD_DEVIATION 3.7
26.1 scores on a scale
STANDARD_DEVIATION 3.5
26.0 scores on a scale
STANDARD_DEVIATION 3.6
26.0 scores on a scale
STANDARD_DEVIATION 3.2
Modified Rankin Scale
Rankin 0 - 1 (no significant disability)
2 participants2 participants0 participants0 participants
Modified Rankin Scale
Rankin 2 (slight disability)
21 participants54 participants21 participants12 participants
Modified Rankin Scale
Rankin 3 (moderate disability)
57 participants172 participants49 participants66 participants
Modified Rankin Scale
Rankin 4 (moderately severe disability)
63 participants180 participants56 participants61 participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants5 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
20 Participants54 Participants15 Participants19 Participants
Race (NIH/OMB)
Black or African American
34 Participants90 Participants24 Participants32 Participants
Race (NIH/OMB)
More than one race
1 Participants3 Participants2 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
9 Participants19 Participants6 Participants4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
77 Participants236 Participants78 Participants81 Participants
Sex: Female, Male
Female
69 Participants184 Participants61 Participants54 Participants
Sex: Female, Male
Male
74 Participants224 Participants65 Participants85 Participants
Side of involvement
Left Hemiparesis
58 participants182 participants61 participants63 participants
Side of involvement
Right Hemiparesis
85 participants226 participants65 participants76 participants
Stroke Type
Hemorrhage
22 participants70 participants21 participants27 participants
Stroke Type
Lacune
45 participants128 participants43 participants40 participants
Stroke Type
Large Vessel
60 participants162 participants47 participants55 participants
Stroke Type
Undefined
16 participants48 participants15 participants17 participants
Time since stroke to randomization - days64.18 days
STANDARD_DEVIATION 9
63.8 days
STANDARD_DEVIATION 8.5
62.9 days
STANDARD_DEVIATION 8
64.1 days
STANDARD_DEVIATION 8.3
Walking Speed (m/sec)
Moderate Disability (0.4 - 0.8 m/sec)
66 participants190 participants60 participants64 participants
Walking Speed (m/sec)
Severe Disability (<0.4 m/sec)
77 participants218 participants66 participants75 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
100 / 139101 / 14388 / 126
serious
Total, serious adverse events
51 / 13959 / 14339 / 126

Outcome results

Primary

Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke

Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.

Time frame: 12 months post-stroke

Population: Intention to treat analysis. Missing data were imputed using the LOCF method.

ArmMeasureValue (NUMBER)
Early Locomotor Training ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke50.4 percent of participants
Late Locomotor Training ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke53.8 percent of participants
Home Exercise ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke51.6 percent of participants
Comparison: Logistic regression was used to compare the proportion of participants who improved functional level of walking between Early-LTP and HEP adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression). Assuming that 30% of HEP participants would improve functional level of walking, we derived a sample size of 400 to detect a clinically relevant 20% effect size with 85% power, adjusting for an loss-to-follow-up rate of 15%.p-value: 0.48195% CI: [0.497, 1.391]Regression, Logistic
Comparison: Logistic regression was used to compare the proportion of participants who improved functional level of walking between Late-LTP and HEP adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).p-value: 0.50195% CI: [0.715, 1.985]Regression, Logistic
Primary

Walking Speed: Measured During a 10-meter Walk

Time frame: Baseline and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramWalking Speed: Measured During a 10-meter WalkBaseline0.37 m/secStandard Deviation 0.22
Early Locomotor Training ProgramWalking Speed: Measured During a 10-meter Walk12-month change from Baseline0.23 m/secStandard Deviation 0.2
Late Locomotor Training ProgramWalking Speed: Measured During a 10-meter WalkBaseline0.38 m/secStandard Deviation 0.23
Late Locomotor Training ProgramWalking Speed: Measured During a 10-meter Walk12-month change from Baseline0.24 m/secStandard Deviation 0.23
Home Exercise ProgramWalking Speed: Measured During a 10-meter WalkBaseline0.39 m/secStandard Deviation 0.22
Home Exercise ProgramWalking Speed: Measured During a 10-meter Walk12-month change from Baseline0.25 m/secStandard Deviation 0.22
Comparison: The second primary analysis assessed the timing effect and its interaction with initial severity of gait impairment on walking speed change from baseline to 1 year after stroke.p-value: 0.242Regression, Linear
Secondary

6 Minute Walking Distance (Meters)

Distance walked in 6 minutes.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training Program6 Minute Walking Distance (Meters)Baseline124.1 metersStandard Deviation 77.5
Early Locomotor Training Program6 Minute Walking Distance (Meters)6-month change from baseline81.8 metersStandard Deviation 62.8
Early Locomotor Training Program6 Minute Walking Distance (Meters)12-month change from baseline73.2 metersStandard Deviation 69.4
Late Locomotor Training Program6 Minute Walking Distance (Meters)12-month change from baseline79.0 metersStandard Deviation 75.1
Late Locomotor Training Program6 Minute Walking Distance (Meters)6-month change from baseline41.0 metersStandard Deviation 47.4
Late Locomotor Training Program6 Minute Walking Distance (Meters)Baseline125.7 metersStandard Deviation 81.8
Home Exercise Program6 Minute Walking Distance (Meters)12-month change from baseline85.2 metersStandard Deviation 72.9
Home Exercise Program6 Minute Walking Distance (Meters)6-month change from baseline75.9 metersStandard Deviation 69.3
Home Exercise Program6 Minute Walking Distance (Meters)Baseline126.3 metersStandard Deviation 75
Comparison: Primary 12 month analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.45ANOVA
Comparison: 6 month secondary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: <0.001ANOVA
Secondary

6 Month Outcome: Walking Speed: Measured During a 10-meter Walk

Time frame: Baseline and 6 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training Program6 Month Outcome: Walking Speed: Measured During a 10-meter WalkBaseline0.37 m/secStandard Deviation 0.22
Early Locomotor Training Program6 Month Outcome: Walking Speed: Measured During a 10-meter Walk6 month change from Baseline0.25 m/secStandard Deviation 0.21
Late Locomotor Training Program6 Month Outcome: Walking Speed: Measured During a 10-meter WalkBaseline0.38 m/secStandard Deviation 0.23
Late Locomotor Training Program6 Month Outcome: Walking Speed: Measured During a 10-meter Walk6 month change from Baseline0.13 m/secStandard Deviation 0.14
Home Exercise Program6 Month Outcome: Walking Speed: Measured During a 10-meter WalkBaseline0.39 m/secStandard Deviation 0.22
Home Exercise Program6 Month Outcome: Walking Speed: Measured During a 10-meter Walk6 month change from Baseline0.23 m/secStandard Deviation 0.2
Comparison: 6 month secondary analysis. Following the overall ANOVA test, pairwise comparison was conducted to assess differences in walking speed changes between early-LTP and late-LTP.p-value: <0.000195% CI: [0.08, 0.16]t-test, 2 sided
Comparison: 6 month secondary analysis. Following the overall ANOVA test, pairwise comparison was conducted to assess differences in walking speed changes between HEP and late-LTP.p-value: <0.000195% CI: [0.05, 0.14]t-test, 2 sided
Secondary

Activities Specific Balance Confidence (ABC) Score

Range = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramActivities Specific Balance Confidence (ABC) Score6-month change from Baseline13.8 units on a scaleStandard Deviation 20.8
Early Locomotor Training ProgramActivities Specific Balance Confidence (ABC) ScoreBaseline43.6 units on a scaleStandard Deviation 23.5
Early Locomotor Training ProgramActivities Specific Balance Confidence (ABC) Score12-month change from Baseline11.2 units on a scaleStandard Deviation 22.3
Late Locomotor Training ProgramActivities Specific Balance Confidence (ABC) Score6-month change from Baseline6.2 units on a scaleStandard Deviation 20.2
Late Locomotor Training ProgramActivities Specific Balance Confidence (ABC) ScoreBaseline47.0 units on a scaleStandard Deviation 25.4
Late Locomotor Training ProgramActivities Specific Balance Confidence (ABC) Score12-month change from Baseline11.7 units on a scaleStandard Deviation 22.1
Home Exercise ProgramActivities Specific Balance Confidence (ABC) ScoreBaseline44.5 units on a scaleStandard Deviation 22.6
Home Exercise ProgramActivities Specific Balance Confidence (ABC) Score12-month change from Baseline13.9 units on a scaleStandard Deviation 21.7
Home Exercise ProgramActivities Specific Balance Confidence (ABC) Score6-month change from Baseline15.6 units on a scaleStandard Deviation 19.4
Comparison: 12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.62ANOVA
Comparison: 6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: <0.001ANOVA
Secondary

Berg Balance Score

Range = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramBerg Balance Score6-month change from Baseline8.8 units on a scaleStandard Deviation 8.1
Early Locomotor Training ProgramBerg Balance ScoreBaseline35.0 units on a scaleStandard Deviation 14.4
Early Locomotor Training ProgramBerg Balance Score12-month change from Baseline8.0 units on a scaleStandard Deviation 7.8
Late Locomotor Training ProgramBerg Balance Score6-month change from Baseline5.3 units on a scaleStandard Deviation 7
Late Locomotor Training ProgramBerg Balance ScoreBaseline35.9 units on a scaleStandard Deviation 14.1
Late Locomotor Training ProgramBerg Balance Score12-month change from Baseline5.9 units on a scaleStandard Deviation 9.1
Home Exercise ProgramBerg Balance ScoreBaseline36.5 units on a scaleStandard Deviation 13.6
Home Exercise ProgramBerg Balance Score12-month change from Baseline8.3 units on a scaleStandard Deviation 8.8
Home Exercise ProgramBerg Balance Score6-month change from Baseline7.9 units on a scaleStandard Deviation 8.5
Comparison: 12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.06ANOVA
Comparison: 6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.001ANOVA
Secondary

Fugl-Meyer Lower Extremity Score

Range 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramFugl-Meyer Lower Extremity Score6-month change from Baseline2.2 units on a scaleStandard Deviation 3.4
Early Locomotor Training ProgramFugl-Meyer Lower Extremity ScoreBaseline23.7 units on a scaleStandard Deviation 6.7
Early Locomotor Training ProgramFugl-Meyer Lower Extremity Score12-month change from Baseline1.7 units on a scaleStandard Deviation 3.9
Late Locomotor Training ProgramFugl-Meyer Lower Extremity Score6-month change from Baseline1.3 units on a scaleStandard Deviation 3.3
Late Locomotor Training ProgramFugl-Meyer Lower Extremity ScoreBaseline24.8 units on a scaleStandard Deviation 6.4
Late Locomotor Training ProgramFugl-Meyer Lower Extremity Score12-month change from Baseline1.5 units on a scaleStandard Deviation 3.7
Home Exercise ProgramFugl-Meyer Lower Extremity ScoreBaseline24.7 units on a scaleStandard Deviation 6.3
Home Exercise ProgramFugl-Meyer Lower Extremity Score12-month change from Baseline2.5 units on a scaleStandard Deviation 4.3
Home Exercise ProgramFugl-Meyer Lower Extremity Score6-month change from Baseline2.4 units on a scaleStandard Deviation 4.1
Comparison: 12 month primary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.13ANOVA
Comparison: 6 month secondary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.04ANOVA
Secondary

Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke

Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.

Time frame: Baseline and 6 months post-stroke

Population: Intention to treat analysis. Missing data were imputed using the Last Observation Carried Forward (LOCF) method.

ArmMeasureValue (NUMBER)
Early Locomotor Training ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke50.4 percent of participants
Late Locomotor Training ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke32.2 percent of participants
Home Exercise ProgramPercentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke49.2 percent of participants
Comparison: Logistic regression was used to compare the proportion of participants who improved functional level of walking between early-LTP and Late-LTP (Usual Care) adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).p-value: 0.0195% CI: [1.18, 3.21]Regression, Logistic
Comparison: Logistic regression was used to compare the proportion of participants who improved functional level of walking between HEP and Late-LTP (Usual Care) adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).p-value: 0.00795% CI: [1.22, 3.42]Regression, Logistic
Secondary

Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day

As measured with a step activity monitor averaged over 2 days.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEDIAN)
Early Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day6-month change from Baseline1017 steps
Early Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per DayBaseline1468 steps
Early Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day12-month change from Baseline858 steps
Late Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day6-month change from Baseline565.5 steps
Late Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per DayBaseline1664 steps
Late Locomotor Training ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day12-month change from Baseline1022 steps
Home Exercise ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per DayBaseline1882.5 steps
Home Exercise ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day12-month change from Baseline1471 steps
Home Exercise ProgramStep Activity Monitor (SAM)- Median of Average Number of Steps Per Day6-month change from Baseline1357 steps
Comparison: 12 month primary outcome. The Kruskal-Wallis procedure was used to assess differences across the three groups in number of steps taken in the community. Wilcoxon signed rank tests were used to compare within-group improvements.p-value: 0.1Kruskal-Wallis
Comparison: 6 month secondary analysis. The Kruskal-Wallis procedure was used to assess differences across the three groups in number of steps taken in the community. Wilcoxon signed rank tests were used to compare within-group improvements.p-value: 0.04Kruskal-Wallis
Secondary

Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)

Range 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)6-month change from baseline9.8 units on a scaleStandard Deviation 17.2
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)Baseline54.1 units on a scaleStandard Deviation 20.1
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)12-month change from baseline9.6 units on a scaleStandard Deviation 19.5
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)6-month change from baseline7.0 units on a scaleStandard Deviation 17.8
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)Baseline55.7 units on a scaleStandard Deviation 20.4
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)12-month change from baseline9.4 units on a scaleStandard Deviation 17.2
Home Exercise ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)Baseline54.4 units on a scaleStandard Deviation 20.7
Home Exercise ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)12-month change from baseline14.5 units on a scaleStandard Deviation 19
Home Exercise ProgramStroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)6-month change from baseline13.0 units on a scaleStandard Deviation 16.9
Comparison: 12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.07ANOVA
Comparison: 6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.03ANOVA
Secondary

Stroke Impact Scale (SIS) - Mobility

Range = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Mobility6-month change from baseline15.3 units on a scaleStandard Deviation 21.4
Early Locomotor Training ProgramStroke Impact Scale (SIS) - MobilityBaseline57.0 units on a scaleStandard Deviation 22.1
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Mobility12-month change from baseline13.7 units on a scaleStandard Deviation 21.6
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Mobility6-month change from baseline7.0 units on a scaleStandard Deviation 15.7
Late Locomotor Training ProgramStroke Impact Scale (SIS) - MobilityBaseline60.5 units on a scaleStandard Deviation 20.7
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Mobility12-month change from baseline12.0 units on a scaleStandard Deviation 19.1
Home Exercise ProgramStroke Impact Scale (SIS) - MobilityBaseline59.1 units on a scaleStandard Deviation 19.5
Home Exercise ProgramStroke Impact Scale (SIS) - Mobility12-month change from baseline14.2 units on a scaleStandard Deviation 20.3
Home Exercise ProgramStroke Impact Scale (SIS) - Mobility6-month change from baseline14.9 units on a scaleStandard Deviation 20
Comparison: 12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.69ANOVA
Comparison: 6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: <0.0001ANOVA
Secondary

Stroke Impact Scale (SIS) - Participation

Range = 0 - 100. The Stroke Impact Scale is a measure of function (including ADL-IADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.

Time frame: Baseline, 6 months and 12 months post-stroke

ArmMeasureGroupValue (MEAN)Dispersion
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Participation6 month change from Baseline11.8 units on a scaleStandard Deviation 26.8
Early Locomotor Training ProgramStroke Impact Scale (SIS) - ParticipationBaseline45.0 units on a scaleStandard Deviation 23.3
Early Locomotor Training ProgramStroke Impact Scale (SIS) - Participation12 month change from Baseline17.1 units on a scaleStandard Deviation 25.9
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Participation6 month change from Baseline7.7 units on a scaleStandard Deviation 20.5
Late Locomotor Training ProgramStroke Impact Scale (SIS) - ParticipationBaseline46.6 units on a scaleStandard Deviation 23
Late Locomotor Training ProgramStroke Impact Scale (SIS) - Participation12 month change from Baseline13.1 units on a scaleStandard Deviation 22
Home Exercise ProgramStroke Impact Scale (SIS) - ParticipationBaseline44.8 units on a scaleStandard Deviation 23.5
Home Exercise ProgramStroke Impact Scale (SIS) - Participation12 month change from Baseline14.4 units on a scaleStandard Deviation 20.6
Home Exercise ProgramStroke Impact Scale (SIS) - Participation6 month change from Baseline14.7 units on a scaleStandard Deviation 22.9
Comparison: 12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.48ANOVA
Comparison: 6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.p-value: 0.06ANOVA

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026